|
1 |
|
00:00:01,260 --> 00:00:05,520 |
|
ุจุณู
ุงููู ุงูุฑุญู
ู ุงูุฑุญูู
ูุชุญุฏุซ ุงูููู
ุนู ุงู |
|
|
|
2 |
|
00:00:05,520 --> 00:00:10,060 |
|
immunodeficiency syndrome ู ุงู immunodeficiency |
|
|
|
3 |
|
00:00:10,060 --> 00:00:17,340 |
|
syndrome ููู ู
ูุณู
ุฉ ู
ุฑุฉ |
|
|
|
4 |
|
00:00:17,340 --> 00:00:21,500 |
|
ุฃุฎุฑู ุจุณู
ุงููู ุงูุฑุญู
ู ุงูุฑุญูู
ูุชุญุฏุซ ุงูููู
ุนู ุงู |
|
|
|
5 |
|
00:00:21,500 --> 00:00:25,780 |
|
immunodeficiency syndrome these are divided into |
|
|
|
6 |
|
00:00:25,780 --> 00:00:30,720 |
|
two major categories ูุณู
ูุงูู
ุฅูู ูุณู
ูู ุฃุณุงุณููู |
|
|
|
7 |
|
00:00:30,720 --> 00:00:33,260 |
|
ููู primary immune deficiency ู ููู secondary |
|
|
|
8 |
|
00:00:33,260 --> 00:00:38,740 |
|
immune deficiency ุทุจุนุง ูู ููุชุง ุงูุญุงูุชูู ููุงู ุญุงูุงุช |
|
|
|
9 |
|
00:00:38,740 --> 00:00:43,460 |
|
ู
ุฑุถูุฉ ู
ุชุจุงููุฉ ุณูุชุทุฑู ูุฃู
ุซูุฉ ูุซูุฑุฉ ูู ูู ููุน ู
ู ูุฐู |
|
|
|
10 |
|
00:00:43,460 --> 00:00:52,620 |
|
ุงูุฃููุงุน the categories |
|
|
|
11 |
|
00:00:52,620 --> 00:00:58,050 |
|
of primary immune response ุงู deficiency ุทูุจ ูุญู |
|
|
|
12 |
|
00:00:58,050 --> 00:01:01,030 |
|
ุณูุชุทุฑู ูู ุงูุจุฏุงูุฉ ูู primary immune deficiency ุซู
|
|
|
|
13 |
|
00:01:01,030 --> 00:01:04,310 |
|
ุณูุชูู ุงูู ุงู secondary immune deficiency ุฌุงูุง ูู |
|
|
|
14 |
|
00:01:04,310 --> 00:01:08,130 |
|
ุงู primary immune deficiency ูู ุนุจุงุฑุฉ ุนู ุนูุงู
ู |
|
|
|
15 |
|
00:01:08,130 --> 00:01:12,970 |
|
ุฃุณุงุณูุฉ ูู immune response ุฃู ุจุงูุชุงูู ูุชุญุฏุซ ุนู T |
|
|
|
16 |
|
00:01:12,970 --> 00:01:17,410 |
|
cell ูุนูู cell mediated immunity ู ูุชุญุฏุซ ุนู B |
|
|
|
17 |
|
00:01:17,410 --> 00:01:21,070 |
|
cell ูุนูู antibody mediated immunity ูุชุญุฏุซ ุนู |
|
|
|
18 |
|
00:01:21,070 --> 00:01:28,590 |
|
both B and T cell immunity ุซู
Non-specific immunity |
|
|
|
19 |
|
00:01:28,590 --> 00:01:36,490 |
|
ู
ุชู
ุซูุฉ ุจุงููุงุฌูุณูุชู ุณูู and or ุงููู ุณูู ุซู
ุงู |
|
|
|
20 |
|
00:01:36,490 --> 00:01:42,490 |
|
complement activation ุฃูุถุง ูุทุจุนุง ูู ูุฐู ุงูุนูุงู
ู |
|
|
|
21 |
|
00:01:42,490 --> 00:01:48,190 |
|
ู
ุดุชุฑูุฉ ุจุชู
ุซู ุงู category of primary immune |
|
|
|
22 |
|
00:01:48,190 --> 00:01:52,070 |
|
response ุณูุชุทุฑู ุงูู ูู ุนุงู
ู ู
ู ูุฐู ุงูุนูุงู
ู ู ูุฃุฎุฐ |
|
|
|
23 |
|
00:01:52,070 --> 00:01:57,100 |
|
ุฃู
ุซูุฉ ุจุฏุงูุฉ ู
ุง ูุชุด ุจุชุดู ูู ูุฌูุฏ immunodeficiency |
|
|
|
24 |
|
00:01:57,100 --> 00:02:05,380 |
|
ูุงููุง ููู ุนุดุฑ ู
ุญุงุฐูุฑ ุฃุณุงุณูุฉ ู
ุธุงูุฑ ุฃุณุงุณูุฉ for |
|
|
|
25 |
|
00:02:05,380 --> 00:02:10,740 |
|
immunodeficiency disease ูู
ุฑุง ูุงุญุฏ six or more |
|
|
|
26 |
|
00:02:10,740 --> 00:02:14,320 |
|
infections per year ูุนูู ุฃูุซุฑ ู
ู ุณุช ู
ุฑุงุช ุชุญุตู ูููุง |
|
|
|
27 |
|
00:02:14,320 --> 00:02:17,820 |
|
infection ูู ุงูุณูุฉ ูู
ุฑุง ุงุชููู two or more severe |
|
|
|
28 |
|
00:02:17,820 --> 00:02:22,360 |
|
sinusitis per year ูู
ุฑุง ุชูุงุชุฉ antibiotic treatment |
|
|
|
29 |
|
00:02:22,360 --> 00:02:27,780 |
|
lasting for two months or even longer ุจุฏูู ุฃู |
|
|
|
30 |
|
00:02:27,780 --> 00:02:33,900 |
|
visible effect ูู
ุฑุง ุฃุฑุจุนุฉ two or more pneumonia |
|
|
|
31 |
|
00:02:33,900 --> 00:02:39,800 |
|
per year ูู
ุฑุง ุฎู
ุณุฉ retardation of growth and |
|
|
|
32 |
|
00:02:39,800 --> 00:02:44,920 |
|
development of child ูู
ุฑุง ุณุชุฉ recurrent deep skin |
|
|
|
33 |
|
00:02:44,920 --> 00:02:50,610 |
|
or organ abscesses ูู
ุฑุฉ ุณุจุนุฉ ู
ูููุณูุณ ู
ุณุชู
ุฑ ูู ุงูุนู
ู |
|
|
|
34 |
|
00:02:50,610 --> 00:02:52,630 |
|
ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู |
|
|
|
35 |
|
00:02:52,630 --> 00:02:56,110 |
|
ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู |
|
|
|
36 |
|
00:02:56,110 --> 00:02:57,110 |
|
ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู |
|
|
|
37 |
|
00:02:57,110 --> 00:02:57,130 |
|
ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู |
|
|
|
38 |
|
00:02:57,130 --> 00:02:57,530 |
|
ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู |
|
|
|
39 |
|
00:02:57,530 --> 00:02:57,610 |
|
ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู |
|
|
|
40 |
|
00:02:57,610 --> 00:03:01,590 |
|
ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู |
|
|
|
41 |
|
00:03:01,590 --> 00:03:10,320 |
|
ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ุนู
ู ูู
ุฑุง ุชุณุนุฉ two or more severe |
|
|
|
42 |
|
00:03:10,320 --> 00:03:14,740 |
|
infection ุฒู encephalitis, osteitis, dermatitis, |
|
|
|
43 |
|
00:03:14,860 --> 00:03:19,440 |
|
myositis and sepsis ูู
ุฑุง ุนุดุฑุฉ family history |
|
|
|
44 |
|
00:03:19,440 --> 00:03:27,680 |
|
indicating primary immune deficiency ุทุจุนุง ูู ุนูุฏูุง |
|
|
|
45 |
|
00:03:27,680 --> 00:03:32,980 |
|
ุฌุฏูู ุฅู ุดุงุก ุงููู ุณูุชุทุฑู ุฅููู ู ูุจูู ููุง |
|
|
|
46 |
|
00:03:32,980 --> 00:03:37,090 |
|
different types of infection ุนูู ุณุจูู ุงูู
ุซุงู ูุงูุช |
|
|
|
47 |
|
00:03:37,090 --> 00:03:41,670 |
|
ุจูุชูุฑูุง ุงููุทุงุนุชุณ ู
ูุฏูุง ู ุจูุชูุฑูุง ุงูููู
ูููุง ุบุงูุจุง |
|
|
|
48 |
|
00:03:41,670 --> 00:03:44,470 |
|
ูุฑุงูุง ูู ุงููุงุณ ุงููู ุนูุฏูู
B cell and antibody |
|
|
|
49 |
|
00:03:44,470 --> 00:03:49,970 |
|
deficiency ู ููุฐุง ุฌุฏูู ู
ุตูู ุงููุง ุจุงูุฐุงุช ุฃู
ุฑุงุถ |
|
|
|
50 |
|
00:03:49,970 --> 00:03:56,590 |
|
ูุซูุฑุฉ ู ุบูุงุจ ูู ูุงุญุฏ ุดู ุจูุนู
ู ูุฃูู ูุงุญุฏ B cell ุฃู |
|
|
|
51 |
|
00:03:56,590 --> 00:04:01,420 |
|
B lymphocyte deficiency which means deficiency in |
|
|
|
52 |
|
00:04:01,420 --> 00:04:05,600 |
|
antibody-mediated immunity ููู ุจูุตูุฑ ููู recurrent |
|
|
|
53 |
|
00:04:05,600 --> 00:04:08,260 |
|
bacterial infection ู ุชุนุชุจุฑ recurrent infection |
|
|
|
54 |
|
00:04:08,260 --> 00:04:11,960 |
|
ู ููุฐุง T cell deficiency ูุนูู cell-mediated |
|
|
|
55 |
|
00:04:11,960 --> 00:04:15,920 |
|
immunity deficiency ูุฒูุฏ ุงู susceptibility to the |
|
|
|
56 |
|
00:04:15,920 --> 00:04:19,460 |
|
viral fungal protozoa ู ุงู infection ููู ู
ุฌู
ูุนุฉ |
|
|
|
57 |
|
00:04:19,460 --> 00:04:24,820 |
|
ูุจูุฑุฉ ู
ู ุนูุด ู
ู ุงูุญุงูุงุช ุงูู
ุฑุถูุฉ ูู ูุงุญุฏ ูู ุนูุด ูู |
|
|
|
58 |
|
00:04:24,820 --> 00:04:27,080 |
|
ุงู associated disease |
|
|
|
59 |
|
00:04:29,920 --> 00:04:32,720 |
|
ุชุฎูู ุงููุง ูุจุฏุฃ ูุญูู ุนููุง ุงู primary |
|
|
|
60 |
|
00:04:32,720 --> 00:04:38,440 |
|
immunodeficiency syndromes ูุนูู ุจุงุณุชุซูุงุก ุงู IGA |
|
|
|
61 |
|
00:04:38,440 --> 00:04:42,260 |
|
deficiency ุงู frequency of immunodeficiency is |
|
|
|
62 |
|
00:04:42,260 --> 00:04:48,460 |
|
very low ุญุฏุฏููุง ูุงุญุฏ ูู ูู ุนุดุฑ ุชูุงู ุฎู
ุณูู ุจุงูู
ุฆุฉ |
|
|
|
63 |
|
00:04:48,460 --> 00:04:53,520 |
|
ู
ููู
associated with antibody deficiency ุนุดุฑูู |
|
|
|
64 |
|
00:04:53,520 --> 00:04:59,350 |
|
ุจุงูู
ุฆุฉ ู
ููู
associated with combined deficiency ุจู
ุนูู ุงูู |
|
|
|
65 |
|
00:04:59,350 --> 00:05:03,850 |
|
ููู antibody ู cell-mediated immunity 18% for |
|
|
|
66 |
|
00:05:03,850 --> 00:05:07,590 |
|
phagocystic disorders 10% for cell-mediated |
|
|
|
67 |
|
00:05:07,590 --> 00:05:15,810 |
|
immunity alone ุงูููุฑุฉ ุงููุงุฏู
ุฉ P1.1 ูุจูู ุงู ูู ู
ุง |
|
|
|
68 |
|
00:05:15,810 --> 00:05:20,830 |
|
ูุงู ุงู defect earlier ูู ู
ุง ูุงู ุงู genetic defect |
|
|
|
69 |
|
00:05:20,830 --> 00:05:24,830 |
|
ุฃู ุงู block ุญุฏุซ |
|
|
|
70 |
|
00:05:24,830 --> 00:05:30,330 |
|
ูู ุฏุฑุงุนู ุงููู ูู ุงูุฌูุงุฒ ุงูู
ูุงุนู ูู ู
ุง ูุงู earlier |
|
|
|
71 |
|
00:05:30,330 --> 00:05:38,850 |
|
ูู ู
ุง ูุงู ุงู effect more severe and diseaseable |
|
|
|
72 |
|
00:05:38,850 --> 00:05:45,160 |
|
ุดูููุง ุงููุฌุฑ ุทุจุนุง ูุฐุง figure ุงููู ุฃูุชู
ุดุงูููู ูุจูู |
|
|
|
73 |
|
00:05:45,160 --> 00:05:51,460 |
|
ุงู ุงู hemopoietic maturation steps for both T and |
|
|
|
74 |
|
00:05:51,460 --> 00:05:58,400 |
|
B lymphocytes ู I ุจู ุนูู ุณุจูู ุงูู
ุซุงู ุจุฏุงูุชูุง |
|
|
|
75 |
|
00:05:58,400 --> 00:06:04,050 |
|
lymphoid stem cell ุซู
pre-cell ุซู
immature cell ุซู
|
|
|
|
76 |
|
00:06:04,050 --> 00:06:07,970 |
|
ุงู mature ุจูู lymphocytes ุงููู ุทุจุนุง ุจุนุฏูุง ุจุชุฏููุง |
|
|
|
77 |
|
00:06:07,970 --> 00:06:12,430 |
|
different types of antibody once ุงููู ูู |
|
|
|
78 |
|
00:06:12,430 --> 00:06:18,090 |
|
maturation occur to plasma cell ูู ูู ู
ุฑุญูุฉ ู
ู |
|
|
|
79 |
|
00:06:18,090 --> 00:06:23,570 |
|
ุงูู
ุฑุงุญู ู
ู
ูู ูุญุตู ููู defect ู ูู ู
ุฑุญูุฉ ู
ู ุงูู
ุฑุงุญู |
|
|
|
80 |
|
00:06:23,570 --> 00:06:27,950 |
|
associated with certain disease ู ูู ู
ุง ูุงูุช |
|
|
|
81 |
|
00:06:27,950 --> 00:06:36,070 |
|
ุงูู
ุฑุญูุฉ ุฃู ุงูุฎูู ุจุฏุฑู ูู ู
ุง ูุงูุด ูู ุงูู
ุฑุงุญู ุงูุชู |
|
|
|
82 |
|
00:06:36,070 --> 00:06:41,710 |
|
ุชูู ุงูุฎูู ุจุฏูุง ุชุชุนุทู ูุจุงูุชุงูู ูู ู
ุง ูุงู ุงู disease |
|
|
|
83 |
|
00:06:41,710 --> 00:06:45,290 |
|
more severe ููุณ ุงูุญูุงูุฉ ุจุงููุณุจุฉ ูู thymus ุฃู ุงู |
|
|
|
84 |
|
00:06:45,290 --> 00:06:49,750 |
|
telephocytes ูู ุจุชูุฌู ุนูู ุงู thymus |
|
|
|
85 |
|
00:06:52,580 --> 00:06:59,000 |
|
ุจุนุฏ ุฐูู ุชุธูุฑ ูู mature CD4 ุฃู CD8 T lymphocytes |
|
|
|
86 |
|
00:06:59,000 --> 00:07:05,280 |
|
ูุทุจุนุง ุชุดุชุบู ู immune |
|
|
|
87 |
|
00:07:05,280 --> 00:07:10,600 |
|
cell ุงูู
ูู
ุงูุชุจููุง ุฅูู ุงูุฃุฑูุงู
ุงูู
ูุฌูุฏุฉ ูุดูููุง |
|
|
|
88 |
|
00:07:10,600 --> 00:07:15,600 |
|
ูุณู
ูุง ุงูู
ุฑุงุญู ูุฐู ุฅูู ุฃุฑูุงู
ู
ุฎุชููุฉ ู ูู ู
ุฑุญูุฉ |
|
|
|
89 |
|
00:07:15,600 --> 00:07:19,120 |
|
associated ุฒู ู
ุง ููุชููู
or combined with a certain |
|
|
|
90 |
|
00:07:19,120 --> 00:07:24,000 |
|
disease ูุฑู 1 ุนูู ุณุจูู ุงูู
ุซุงู ูู ูุนูู ูู ุจุฏุฑู ุฎุงูุต |
|
|
|
91 |
|
00:07:24,000 --> 00:07:27,120 |
|
ุงูุฎูู ุจูุตูุฑ ูู severe compound immunodeficiency |
|
|
|
92 |
|
00:07:27,120 --> 00:07:32,200 |
|
syndrome ุฑูู
ุงุชููู ุจุฑุถู ุจุฏุฑู ุฃุฏุงุฉ ุจูุตูุฑ ูู |
|
|
|
93 |
|
00:07:32,200 --> 00:07:36,000 |
|
congenital thymic aplasia ูุจุฑุถู ูุฐุง ุนุจุงุฑุฉ ุนู ุฏู |
|
|
|
94 |
|
00:07:36,000 --> 00:07:40,020 |
|
ุฌุงุฑุณ ุณูุฏุฑูู
ูุนูู ู
ุงููุด T lymphocytes ุจุชุชุตูุน ุฃุชูู |
|
|
|
95 |
|
00:07:40,020 --> 00:07:47,480 |
|
ุฑูู
ุชูุงุชุฉ ุฃุฏุงุฉ ุจูุตูุฑ ูู skid ุงูุถุง ุฑูู
ุงุฑุจุน ูู ุงู B |
|
|
|
96 |
|
00:07:47,480 --> 00:07:51,610 |
|
cell ุฃุฏุงุฉ ูุงููุง ุจูุตูุฑ ูู X-Linked E Gamma Global |
|
|
|
97 |
|
00:07:51,610 --> 00:07:58,530 |
|
Anemia ู
ุงููุด ููุง Antibody ุจูุชููู ุฑูู
ุฎู
ุณุฉ ู
ุงุดู ูุฐุง |
|
|
|
98 |
|
00:07:58,530 --> 00:08:03,570 |
|
ูู ุฃูุง ุฑูู
ุฎู
ุณุฉ ุจูุตูุฑ common variable immune |
|
|
|
99 |
|
00:08:03,570 --> 00:08:09,670 |
|
deficiency disease ู ููุฐุง ูู ุงูุญุงูุงุช ุงููู ูู ูู |
|
|
|
100 |
|
00:08:09,670 --> 00:08:16,440 |
|
ุงูู
ุฑุงุญู associated with certain disease ูุจุฏุฃ ุจู |
|
|
|
101 |
|
00:08:16,440 --> 00:08:22,600 |
|
Severe Combined Immunodeficiency Diseases ููู |
|
|
|
102 |
|
00:08:22,600 --> 00:08:26,640 |
|
ุนุจุงุฑุฉ ุนู ููุชุฑูุฌููุณ ุฌุฑูุจ of disease associated or |
|
|
|
103 |
|
00:08:26,640 --> 00:08:29,700 |
|
in which cell-mediated immunity and antibody ูุฃูู |
|
|
|
104 |
|
00:08:29,700 --> 00:08:35,060 |
|
combined production are defected ุงูุงุซููู ู
ุนุทููู |
|
|
|
105 |
|
00:08:35,060 --> 00:08:38,960 |
|
both humoral and cell-mediated immunity are |
|
|
|
106 |
|
00:08:38,960 --> 00:08:44,940 |
|
defected ูู ุงูุฒู
ู ูุชุณู
ููุง ุฃู Swiss-type Aiga |
|
|
|
107 |
|
00:08:44,940 --> 00:08:49,820 |
|
Microbial Anemia ู ุงููุงุณ ูุฏูู ุนุงุฏุฉ susceptible to |
|
|
|
108 |
|
00:08:49,820 --> 00:08:54,060 |
|
virtually every type of microbial infection, viral |
|
|
|
109 |
|
00:08:54,060 --> 00:08:59,040 |
|
infection, bacterial infection, fungal, protozoal |
|
|
|
110 |
|
00:08:59,040 --> 00:09:04,380 |
|
and so on ุฃุดูุฑ ุงูุญุงุฌุงุช ุงููู ู
ูุญูุธุฉ ูู ูุฐุง ุงูููุน ู
ู |
|
|
|
111 |
|
00:09:04,380 --> 00:09:08,380 |
|
ุงูุฃู
ุฑุงุถ ูู Infection of Cytomegalovirus, |
|
|
|
112 |
|
00:09:08,980 --> 00:09:16,220 |
|
Pneumocystitiscarny eye and candida ุทุจุนุง ุงููุงุณ ุฏูู |
|
|
|
113 |
|
00:09:16,220 --> 00:09:23,260 |
|
ู
ู
ููุน ูุงุฎุฏูุง vaccine with attenuated lymph virus |
|
|
|
114 |
|
00:09:23,260 --> 00:09:29,700 |
|
ูุฃูู it will lead to death patient have been |
|
|
|
115 |
|
00:09:29,700 --> 00:09:32,260 |
|
classified according to the following figure or |
|
|
|
116 |
|
00:09:32,260 --> 00:09:40,020 |
|
table ุฌุงุก ูุฏูุง ูุณู
ูู
ู T minus B plus T minus B |
|
|
|
117 |
|
00:09:40,020 --> 00:09:45,920 |
|
minus ุฃููุงุน ู
ุฎุชููุฉ ุณูุชุทุฑู ููู ููุน ู
ู ูุฐู ุงูุฃููุงุน ุจุณ |
|
|
|
118 |
|
00:09:45,920 --> 00:09:51,980 |
|
ูุฌุจ ุฃู ูููู
ุงู T minus ูุนูู ูู ุบูุงุจ ู T cell ุจู |
|
|
|
119 |
|
00:09:51,980 --> 00:09:57,500 |
|
ุจูุณ ูุนูู ูู normal ุจู cell ู ู
ู
ูู ูููู ูู ุบูุงุจ |
|
|
|
120 |
|
00:09:57,500 --> 00:10:02,280 |
|
ู NK cell ูู
ุง ุฃููู T minus ุจู minus ูุนูู ูุง ุจู |
|
|
|
121 |
|
00:10:02,280 --> 00:10:08,780 |
|
ููุง T cell ู
ูุฌูุฏุฉ ู ูู
ุง ุฃููู ุงูุงุซููู plus ู
ุนูุงุชู |
|
|
|
122 |
|
00:10:08,780 --> 00:10:12,080 |
|
ุงููุงุณ ุงูุชุงููุฉ ูุฏูู ุนูุฏูู
T cell ู B cell ููู ูู
ุบูุฑ |
|
|
|
123 |
|
00:10:12,080 --> 00:10:18,840 |
|
ุดุบุงููู ู
ุด ุดุบุงููู T plus B minus it's very rare ู |
|
|
|
124 |
|
00:10:18,840 --> 00:10:23,960 |
|
they preferred treatment ุทุจุนุง ูุญุงูุงุช ู
ู ูุงูููุน ุงูู |
|
|
|
125 |
|
00:10:23,960 --> 00:10:28,460 |
|
ูุนู
ู bone marrow transplantation from an HLA |
|
|
|
126 |
|
00:10:28,460 --> 00:10:33,660 |
|
matched sibling donor ูุฏู ุจูู ููุฐู ุงูุญุงูุงุช ุฃูููุง |
|
|
|
127 |
|
00:10:33,660 --> 00:10:38,340 |
|
ุญุงูุฉ ูู T minus B plus ุงุชูููุง ุนูู ุฃูู ูู ู
ุง ูููุงุด D |
|
|
|
128 |
|
00:10:38,340 --> 00:10:42,000 |
|
-cell ูุฅูู
ุง ู
ุง ููู B-cell ุงูู
ุฑุถ ูุฐุง ุนุจุงุฑุฉ ุนู X |
|
|
|
129 |
|
00:10:42,000 --> 00:10:49,920 |
|
-linked skid ุจูู
ุซู 40 ู 50% ู
ู ุงูุญุงูุงุช ุงููู ุจูุญูู |
|
|
|
130 |
|
00:10:49,920 --> 00:10:54,000 |
|
ุนููุง ุงู mutation ุฌุงูู ู
ูุฌูุฏ ุนูู ุงู X-chromosome |
|
|
|
131 |
|
00:10:54,000 --> 00:10:58,980 |
|
ุงูุฌูู ุงููู ุตุงุฑ ููู mutation ู
ูุฌูุฏ ุนูู ุงู X |
|
|
|
132 |
|
00:10:58,980 --> 00:11:05,180 |
|
-chromosome which could for gamma chain ู
ุงุดู |
|
|
|
133 |
|
00:11:06,650 --> 00:11:12,870 |
|
Gamma Chain Cytokine Receptor ูุทุจุนูุง this Gamma |
|
|
|
134 |
|
00:11:12,870 --> 00:11:17,230 |
|
Chain ุชูุนุจ ุฏูุฑ ูุจูุฑ ูู ุงูู ุงููู ูู Signal |
|
|
|
135 |
|
00:11:17,230 --> 00:11:22,290 |
|
Transduction ูุนุฏุฏ ูุจูุฑ ู
ู ุงู Cytokine ู
ููุง IL2, |
|
|
|
136 |
|
00:11:22,390 --> 00:11:30,110 |
|
IL4, IL7, IL9, IL15 ูุทุจุนุง ูุฐู ู
ุนูุงุชู ุบูุงุจูุง ุจูุนู
ู |
|
|
|
137 |
|
00:11:30,110 --> 00:11:36,930 |
|
ุบูุงุจ ูู ุงู function for this cytokine ููุฐุง ููุฑุฉ |
|
|
|
138 |
|
00:11:36,930 --> 00:11:42,830 |
|
ูุงุถุญ ุฌุฏุง ูู Receptor ุงููู ูู ุนุจุงุฑุฉ ุนู ุฅูุด ligand |
|
|
|
139 |
|
00:11:42,830 --> 00:11:49,870 |
|
ููู ุงู Cytokine ูุฐูู ุงู ligand ุชุนูููู ููู ุงู |
|
|
|
140 |
|
00:11:49,870 --> 00:11:55,690 |
|
Cytokine ูุฐูู ููู ุจุชุชููู ู
ู two chain ูุงุญุฏุฉ ู
ููู
|
|
|
|
141 |
|
00:11:55,690 --> 00:11:58,550 |
|
ุจุชูุนุจ ุฏูุฑ ูุจูุฑ ูู ุงูู |
|
|
|
142 |
|
00:11:58,550 --> 00:12:03,010 |
|
signal transduction ููู ุงู gamma chain gamma chain |
|
|
|
143 |
|
00:12:03,010 --> 00:12:05,690 |
|
ูุจุงูุชุงูู ุบูุงุจูุง ูุนูู ู
ุง ููุด signal transduction |
|
|
|
144 |
|
00:12:05,690 --> 00:12:10,270 |
|
ูุจุงูุชุงูู ู
ุง ููุด transcription for this gene ู
ุงุดู |
|
|
|
145 |
|
00:12:10,270 --> 00:12:16,330 |
|
ูุจุงูุชุงูู ูู ุงู function ููุฐู ุงู Cytokine will be |
|
|
|
146 |
|
00:12:16,330 --> 00:12:22,950 |
|
missed ุงูู
ุฑุถ |
|
|
|
147 |
|
00:12:22,950 --> 00:12:30,260 |
|
ุงูุชุงูู ุงู which ูุนูู similar to this disease ูู |
|
|
|
148 |
|
00:12:30,260 --> 00:12:34,880 |
|
ุบูุงุจ ุงูุฌุฒุก ุงูุชุงูู ู
ู ุงู Receptor ู
ุด ูู ุจูููุจูุจุจุชูุฏ |
|
|
|
149 |
|
00:12:34,880 --> 00:12:39,000 |
|
ุดููู ุฅูู
ุง ูู functioning process ุงููู ูู ุบูุงุจ ุงูู JAK |
|
|
|
150 |
|
00:12:39,000 --> 00:12:44,900 |
|
ููู
ู
ุง ูุตูุฑ ููู ุบูุงุจ ููู JAK ุทุจุนุง ู
ุง ูุตูุฑุด ููู ุชุบูุฑ |
|
|
|
151 |
|
00:12:44,900 --> 00:12:47,440 |
|
ูู ุงู Gamma ูู
ุชู
ุง ุชุบูุฑุช ุจุชุงุนุฉ ุงู Signal |
|
|
|
152 |
|
00:12:47,440 --> 00:12:52,190 |
|
transduction ุบูุงุจ ุงูู JAK ุฃูุถุง ุจุฑุถู ุจูุนู
ู ููุณ ุงูุฃุนุฑุงุถ |
|
|
|
153 |
|
00:12:52,190 --> 00:12:57,950 |
|
ูุจุงูุชุงูู ุจูุตูุฑ ููู ุบูุงุจ ููู signal transduction ูุฐุง |
|
|
|
154 |
|
00:12:57,950 --> 00:13:04,990 |
|
X-linked ูุงูู JAK deficiency ูู ุนุจุงุฑุฉ ุนู ุงุชุฒูู
ุงูู |
|
|
|
155 |
|
00:13:04,990 --> 00:13:12,290 |
|
recessive disease ุฃู |
|
|
|
156 |
|
00:13:12,290 --> 00:13:15,670 |
|
ุงุชุฒูู
ุงูู recessive ูููุง ุบูุงุจ ุงูู JAK ุชูุงุชุฉ ูู |
|
|
|
157 |
|
00:13:15,670 --> 00:13:21,290 |
|
ุนุจุงุฑุฉ ุนู Tyrosine Kinase ูุทุจุนุง ุบูุงุจู ุจูุนูู ู
ุง ููุด |
|
|
|
158 |
|
00:13:21,290 --> 00:13:24,950 |
|
signal transduction ููุฌุฏูุง ุฃู ุงู expression of |
|
|
|
159 |
|
00:13:24,950 --> 00:13:28,530 |
|
JAK ู
ูุฌูุฏ ูู ูู ุงูู hemopoietic cells ูุจุงูุชุงูู |
|
|
|
160 |
|
00:13:28,530 --> 00:13:33,790 |
|
ู
ุง ูุตูุฑุด ูู maturation ููุฎูุงูุง |
|
|
|
161 |
|
00:13:33,790 --> 00:13:40,310 |
|
ูุฐู ุงูููุทุฉ ุงูุชุงููุฉ T minus B minus ูู
ู ุงูุฃู
ุฑุงุถ |
|
|
|
162 |
|
00:13:40,310 --> 00:13:46,830 |
|
ุงูู
ุดุงุฑูุฉ ูู ูุฐุง ุงูู group ูู ุงู adenosine deaminase |
|
|
|
163 |
|
00:13:46,830 --> 00:13:52,160 |
|
deficiency ููุฐุง ุนุจุงุฑุฉ ุนู ุฅูุฒูู
ุจููุนุจ ุฏูุฑ ูุจูุฑ ูู |
|
|
|
164 |
|
00:13:52,160 --> 00:13:59,660 |
|
ุงูู Purine pathway ูู
ุซู 20% ู
ู ุญุงูุงุช ุงูู Skid ููู |
|
|
|
165 |
|
00:13:59,660 --> 00:14:05,260 |
|
ุนุจุงุฑุฉ ุนู autosomal recessive disease ูุบูุงุจู ุจูุนูู |
|
|
|
166 |
|
00:14:05,260 --> 00:14:11,720 |
|
accumulation of toxic wastes ุจูุตูุฑ ูู build up ูู |
|
|
|
167 |
|
00:14:11,720 --> 00:14:20,200 |
|
build up ููุด ููู toxic waste ูู ุงูุฌุณู
ุทุจุนุง it has |
|
|
|
168 |
|
00:14:20,200 --> 00:14:24,340 |
|
greatest impact of the immune ุนูู ุงูุฌูุงุฒ ุงูู
ูุงุนู |
|
|
|
169 |
|
00:14:24,340 --> 00:14:29,880 |
|
ุจูุคุฏู ูู failure ุฃู both T and B cell development ุจุนุฏ |
|
|
|
170 |
|
00:14:29,880 --> 00:14:32,260 |
|
ุชุงูู ุงููู ูู purely nucleotide phosphorylase |
|
|
|
171 |
|
00:14:32,260 --> 00:14:33,020 |
|
deficiency |
|
|
|
172 |
|
00:14:35,470 --> 00:14:39,610 |
|
ูุฐุง ุณูุคุฏู ุฃูุถูุง ุฅูู ุจูุงุก ุชุฌุงุฑุจ ู
ู ุฃุฌูุฒุฉ ู
ุฎุงุทุฑุฉ |
|
|
|
173 |
|
00:14:39,610 --> 00:14:47,910 |
|
ุฎุตูุตูุง ูุฐู ุงูุฃุฌูุฒุฉ ุงูู
ุฎุงุทุฑุฉ ุจุฅู
ูุงููุง ุชุฏู
ุฑ ูุธุงู
|
|
|
|
174 |
|
00:14:47,910 --> 00:14:52,930 |
|
ุงูููู
ูููุฌู ูุจูุฃุซุฑ |
|
|
|
175 |
|
00:14:52,930 --> 00:14:57,570 |
|
ุฃูุถูุง ุนูู ุงูู T-cell ูุจุงูุชุงูู ูู ุงูู lymphocytes |
|
|
|
176 |
|
00:14:57,570 --> 00:15:03,470 |
|
ู
ุฏูููู ููุน ุชุงูู ุงููู ูู Recombinase deficiency |
|
|
|
177 |
|
00:15:04,630 --> 00:15:09,150 |
|
ุฃูุถูุง ุงูู Recombinase Deficiency ูุนุฑู ุฃูู ูู |
|
|
|
178 |
|
00:15:09,150 --> 00:15:13,610 |
|
ุงูุฌููุงุช ุงูู
ุณุคููุฉ ุงููู ูู RAG 1 ู RAG 2 ูู
ุง two |
|
|
|
179 |
|
00:15:13,610 --> 00:15:16,750 |
|
important genes ู
ูุฌูุฏูู ูู ุงูู lymphocytes only |
|
|
|
180 |
|
00:15:16,750 --> 00:15:21,710 |
|
ูุจููุนุจูุง ุฏูุฑ ูุจูุฑ ูู ุงูู rearrangement of both |
|
|
|
181 |
|
00:15:21,710 --> 00:15:28,950 |
|
immunoglobulin gene and TCR gene ูุจุงูุชุงูู ุบูุงุจูู
|
|
|
|
182 |
|
00:15:29,520 --> 00:15:34,520 |
|
ุจูุคุฏู ุฅูู ุฎูู ูู ุงูู gene rearrangement ูุจุงูุชุงูู |
|
|
|
183 |
|
00:15:34,520 --> 00:15:38,600 |
|
ุงูู mutation ุจุชุคุซุฑ ุฅูู complete absence ุชุนู
ู |
|
|
|
184 |
|
00:15:38,600 --> 00:15:43,440 |
|
complete absence ููู T ู B lymphocytes ูุจุงูุชุงูู |
|
|
|
185 |
|
00:15:43,440 --> 00:15:44,540 |
|
ู
ุง ููุด immunoglobulins |
|
|
|
186 |
|
00:15:50,790 --> 00:15:56,210 |
|
ูุจุงูุชุงูู ู
ุง ููุด match or ูุฃ ุชู ููุง ุจู ูุฃู ุงูู |
|
|
|
187 |
|
00:15:56,210 --> 00:16:04,670 |
|
function is intact ุชู ุจูุณ ุจู ู
ุง ุนุฏุง ุฅุฐุง ุจูููููุง |
|
|
|
188 |
|
00:16:06,040 --> 00:16:10,740 |
|
ููุงููุง ุฅู ุฃุดุงุฑูุง ุงูู Omen Syndrome ูุงูู Omen |
|
|
|
189 |
|
00:16:10,740 --> 00:16:17,280 |
|
Syndrome ุฃูุถูุง ูู ุนุจุงุฑุฉ ุนู ุฎูู ุจูุตูุฑ ููู reduction |
|
|
|
190 |
|
00:16:17,280 --> 00:16:21,420 |
|
ูู ุงูู or partial complete or partial reduction of |
|
|
|
191 |
|
00:16:21,420 --> 00:16:27,900 |
|
the RAG genes ูุจุงูุชุงูู ุจูุตูุฑ ููู ุฎูู ูู ุงูู RAG |
|
|
|
192 |
|
00:16:27,900 --> 00:16:32,760 |
|
activity ุงูู clinical presentation ุฒู ูุฒู ุงูู graft |
|
|
|
193 |
|
00:16:32,760 --> 00:16:39,350 |
|
versus host disease ูุงููุงุณ ุฏููุฉ ุชุฏูุน ูุฐู ุงูุชุญูู
ุงุช |
|
|
|
194 |
|
00:16:39,350 --> 00:16:44,390 |
|
ูููุธุงู
ุงูู
ูุงุนู ููู
ูุฏููู
ุฌุณุฏ ูุจูุฑ ุฌู ุชู |
|
|
|
195 |
|
00:16:44,390 --> 00:16:51,550 |
|
infiltration ู
ู ุฒูููููู ูactivated T cell ุชุฏูุนูุง ุงูู |
|
|
|
196 |
|
00:16:51,550 --> 00:16:57,290 |
|
hyper immunoglobulin production of cytokine ููุฐุง ุจููุฏุฑ ุงูู hyper IgE |
|
|
|
197 |
|
00:16:57,290 --> 00:17:00,730 |
|
syndrome ู Job syndrome |
|
|
|
198 |
|
00:17:03,450 --> 00:17:08,590 |
|
ุงูุฎูุงุตุฉ ู
ุฑุถู ู
ู ูุฐุง ุงูููุน ุจูุญุชุงุฌ ุงูู pre |
|
|
|
199 |
|
00:17:08,590 --> 00:17:14,430 |
|
-treatment with immunosuppressive drug ุงูู |
|
|
|
200 |
|
00:17:14,430 --> 00:17:21,550 |
|
T plus B plus subgroup ูู ุงูุชูุชูู ู
ูุฌูุฏูู ููู they |
|
|
|
201 |
|
00:17:21,550 --> 00:17:24,870 |
|
are not functioning ุฃุดูุฑ ูุฐู ุงูุฃู
ุฑุงุถ ุงูู bare |
|
|
|
202 |
|
00:17:24,870 --> 00:17:30,040 |
|
lymphocyte syndrome ุฏู ูู ุจูุคุฏู ุงูู results from |
|
|
|
203 |
|
00:17:30,040 --> 00:17:34,920 |
|
the failure to express HLA molecule ูุงูุณุจุจ ูู ุฐูู |
|
|
|
204 |
|
00:17:34,920 --> 00:17:37,960 |
|
ุทุจุนุง ู
ุง ููุด HLA molecule ูุนูู ู
ุง ููุด antigen |
|
|
|
205 |
|
00:17:37,960 --> 00:17:45,220 |
|
presentation ุจูุงุณุทุฉ ุทุจุนุง ุงููู ูู HLA class 2 |
|
|
|
206 |
|
00:17:45,220 --> 00:17:48,680 |
|
molecule deficiency ูู ุงูุบุงูุจ class 1 ู
ู
ูู ูููู |
|
|
|
207 |
|
00:17:48,680 --> 00:17:54,470 |
|
ู
ุชุฃุซุฑ ูู
ู
ูู ูู circulating T and B cell may be |
|
|
|
208 |
|
00:17:54,470 --> 00:18:00,110 |
|
normal ููู ูู ุบูุงุจ ุงูู HLA class 2 molecule ู
ุง |
|
|
|
209 |
|
00:18:00,110 --> 00:18:07,180 |
|
ุจูุญุตู ููู antigen presentation ูู CD4 T cell ุงูู ZAP |
|
|
|
210 |
|
00:18:07,180 --> 00:18:12,080 |
|
-70 mutation ูู ุนุจุงุฑุฉ ุนู ููู
ููุงู |
|
|
|
211 |
|
00:18:12,080 --> 00:18:19,620 |
|
ู
ูุณูุฌุฑ ุจูุนู
ู ููู ููุฅุดุงุฑุฉ ุจู
ูุฎุฏ |
|
|
|
212 |
|
00:18:19,620 --> 00:18:21,700 |
|
TCR ูููููููุงุณ ููู ููู ููุฅุดุงุฑุฉ ุจู
ูุฎุฏ TCR ูููููููุงุณ |
|
|
|
213 |
|
00:18:21,700 --> 00:18:24,800 |
|
ููู ููู ููุฅุดุงุฑุฉ ุจู
ูุฎุฏ TCR ูููููููุงุณ ููู ููู |
|
|
|
214 |
|
00:18:24,800 --> 00:18:27,880 |
|
ููุฅุดุงุฑุฉ |
|
|
|
215 |
|
00:18:27,880 --> 00:18:31,840 |
|
ุจู
ูุฎุฏ TCR ูููููููุงุณ ุดูููุง ูุฐู ุงูุนูุงูุฉ ู
ุง ุฃุญูุงูุง |
|
|
|
216 |
|
00:18:31,840 --> 00:18:37,580 |
|
ูุนุฑู ุฃูู ูู ุนูุฏูุง antigen presenting cell ู
ุงุดู |
|
|
|
217 |
|
00:18:37,580 --> 00:18:43,160 |
|
ุจุชูุฏู
ุงููู ูู |
|
|
|
218 |
|
00:18:43,160 --> 00:18:47,400 |
|
antigen |
|
|
|
219 |
|
00:18:47,400 --> 00:18:56,040 |
|
ุงูู antigen ูู T-lymphocyte ูุทุจุนูุง ุณูุงุก ูุงูุช ุงูู |
|
|
|
220 |
|
00:18:56,040 --> 00:19:01,140 |
|
Antigen Presenting Cell Macrophage ุฃู B Cell ุชูุชูู |
|
|
|
221 |
|
00:19:01,140 --> 00:19:05,660 |
|
ุจูุฏู
ุงูุงูุชูุฌู ูู
ูุ ูู T-Lymphocyte ุดูููุง ุงุญุชู
ุงูุงุช |
|
|
|
222 |
|
00:19:05,660 --> 00:19:09,340 |
|
ุงูุฎูู ููู ุจุชุตูุฑ ูุจู ุงุญุชู
ุงู ูุตูุฑ ููู ุฎูู ูู ุงูู |
|
|
|
223 |
|
00:19:09,340 --> 00:19:13,220 |
|
MHC Class II ุจูุนู
ู ู
ุฑุถ ูุณู
ููู Bare Lymphocyte |
|
|
|
224 |
|
00:19:13,220 --> 00:19:16,740 |
|
Syndrome ุญุงุฌุฉ ููุงู ู
ุชูู
ุงุญุชู
ุงู ุงูุฎูู ูููู ูู ุงูู |
|
|
|
225 |
|
00:19:16,740 --> 00:19:20,860 |
|
FAS ุฃู ุงูู FAS ligand ู ููุนู
ู FAS Deficiency |
|
|
|
226 |
|
00:19:20,860 --> 00:19:27,110 |
|
Syndrome ูุงุญุชู
ุงู ุงูุฎูู ูููู ูู CD40 ligand ู CD40 |
|
|
|
227 |
|
00:19:27,110 --> 00:19:30,590 |
|
ligand ู
ูุฌูุฏ ุนูู ุงูู T cell ุจูุนู
ู ุญุงุฌุฉ ุจูุณู
ููุง |
|
|
|
228 |
|
00:19:30,590 --> 00:19:37,990 |
|
Hyper IgM Syndrome ุฃุซุฑ |
|
|
|
229 |
|
00:19:37,990 --> 00:19:43,150 |
|
Multi System Disorders ุจุงูุฅุถุงูุฉ ููู SCID ูู SCID |
|
|
|
230 |
|
00:19:43,150 --> 00:19:48,190 |
|
like clinical picture associated with certain |
|
|
|
231 |
|
00:19:48,190 --> 00:19:52,000 |
|
disease ุฒู Wiskott-Aldrich Syndrome ูุฏู ุงุณู
ู |
|
|
|
232 |
|
00:19:52,000 --> 00:19:56,940 |
|
syndrome ุนุจุงุฑุฉ ุนู X-linked disease ุจูุชู
ุซู ุจุงููุงุชู |
|
|
|
233 |
|
00:19:56,940 --> 00:20:00,860 |
|
ุฑูู
ูุงุญุฏ ูู bleeding ูุฃูู ููู thrombocytopenia |
|
|
|
234 |
|
00:20:00,860 --> 00:20:04,340 |
|
ุฑูู
ุงุซููู ูู recurrent bacterial infection ูู |
|
|
|
235 |
|
00:20:04,340 --> 00:20:12,200 |
|
allergic reaction ูู long term patient ู
ู
ูู ูุฌูุจ ูู |
|
|
|
236 |
|
00:20:12,200 --> 00:20:18,680 |
|
malignant disease ูุงูู genetic basis ูุนูู |
|
|
|
237 |
|
00:20:18,680 --> 00:20:24,580 |
|
mutation ูู ุงูู X-linked gene ุงููู ุจูุคุฏู ุงูู a |
|
|
|
238 |
|
00:20:24,580 --> 00:20:29,940 |
|
which code for ููุณููุช ุฃูุฏุฑูุฎ ุณูุฏุฑูู
ุจุฑูุชูู ููุฐุง |
|
|
|
239 |
|
00:20:29,940 --> 00:20:35,400 |
|
ู
ูุฌูุฏ ูู ูู ุงูู hemopoietic stem cells both T and |
|
|
|
240 |
|
00:20:35,400 --> 00:20:38,220 |
|
B cell are functionally non-abnormal |
|
|
|
241 |
|
00:20:40,700 --> 00:20:47,340 |
|
ูุจุงูุชุงูู ูุง ูู
ูู ููุดุฎุต ุฃู ูุชูุงุนู ุจู Polysaccharide |
|
|
|
242 |
|
00:20:47,340 --> 00:20:51,640 |
|
Antigen ุงูุชุนุงู
ู ูู ูุฐู ุงูุญุงูุฉ ูุญุชุงุฌ ุฅูู Antibiotic |
|
|
|
243 |
|
00:20:51,640 --> 00:20:57,600 |
|
ู Antiviral ู Bone marrow transplantation ูุจุฏูู ูุฐุง |
|
|
|
244 |
|
00:20:57,600 --> 00:21:02,260 |
|
ุงูุนูุงุฌ ุงูู life expectancy ูุง ุชุชุนุฏู ุชูุช ุณููุงุช |
|
|
|
245 |
|
00:21:02,260 --> 00:21:09,180 |
|
ุฃุชุงูุณูุง ุชูุงูุฌููุชุงุฒูุง ู
ู ุงููุตูุฑ ุจุฑุถู ู
ุฑุถู system |
|
|
|
246 |
|
00:21:09,180 --> 00:21:14,320 |
|
genetic disorders ุจูุชู
ุซู ุจุงููุงุชู ุจูุตูุฑ ููู jerky |
|
|
|
247 |
|
00:21:14,320 --> 00:21:19,480 |
|
movement or lack of muscle coordination ููู
ุฑ ุงุซููู |
|
|
|
248 |
|
00:21:19,480 --> 00:21:24,170 |
|
abnormal vascular dilatation ุชูุงูุฌููุชุงุฒูุฉ ูู ุงูู eye |
|
|
|
249 |
|
00:21:24,170 --> 00:21:28,570 |
|
ูุงูู skin ู ุจุฒูุงุฏุฉ ุงู susceptibility to infection |
|
|
|
250 |
|
00:21:28,570 --> 00:21:34,870 |
|
ุจูุตูุฑ ููููู
ุฉ ูุงูู defect ูู ุงูู both B ู T cell |
|
|
|
251 |
|
00:21:34,870 --> 00:21:40,270 |
|
ุงู gene ุทุจุนุง of ataxia telangiectasia codes for a |
|
|
|
252 |
|
00:21:40,270 --> 00:21:46,490 |
|
protein known as ATM. ุงูุฃุทูุงู have a risk for |
|
|
|
253 |
|
00:21:46,490 --> 00:21:51,870 |
|
developing malignancy ุฎุตูุตุง ุงู lymphoid neoplasm |
|
|
|
254 |
|
00:21:55,810 --> 00:22:01,390 |
|
ุงูู category ุงูุซุงูู ูู ุงู immune deficiency |
|
|
|
255 |
|
00:22:01,390 --> 00:22:04,030 |
|
disorder associated with T cell and cell-mediated |
|
|
|
256 |
|
00:22:04,030 --> 00:22:08,510 |
|
immunity. ูุงููุง ุงููุงุณ ูุฏููุฉ ู
ุด ุนูุฏูู
T cell |
|
|
|
257 |
|
00:22:08,510 --> 00:22:12,790 |
|
associated deficiency disease. ุฅููู ุงุชูููุง ุนูู ุฃู ุงู |
|
|
|
258 |
|
00:22:12,790 --> 00:22:19,090 |
|
T cell deficiency ู
ุงููุด associated with ุงููู ูู |
|
|
|
259 |
|
00:22:19,090 --> 00:22:21,810 |
|
disease ุฒู ุงู viral, fungal, protozoal infection |
|
|
|
260 |
|
00:22:23,590 --> 00:22:26,890 |
|
ููููุง ุจูุนุฑู ุฅู ุงูู T-Lymphocyte ุจุชุณุงุนุฏ ุงูู B |
|
|
|
261 |
|
00:22:26,890 --> 00:22:30,730 |
|
-Lymphocyte ูู ุฅูุชุงุฌ ุงูู antibody, which antibody |
|
|
|
262 |
|
00:22:30,730 --> 00:22:36,430 |
|
would form T cell dependent antigen. ูุบูุงุจ or T |
|
|
|
263 |
|
00:22:36,430 --> 00:22:40,810 |
|
cell associated deficiency ููุนู
ู selective defect |
|
|
|
264 |
|
00:22:40,810 --> 00:22:46,170 |
|
in antibody production. ูุจุงูุชุงูู T cell deficient |
|
|
|
265 |
|
00:22:46,170 --> 00:22:51,430 |
|
patient have difficulty to distinguish, have |
|
|
|
266 |
|
00:22:51,430 --> 00:22:55,850 |
|
difficulty to distinguish clinically to be |
|
|
|
267 |
|
00:22:55,850 --> 00:23:00,270 |
|
distinguished clinically from a septic patient. ู
ุง |
|
|
|
268 |
|
00:23:00,270 --> 00:23:05,450 |
|
ุฒุงู ุงู B ู ุงู T ู
ุด ู
ูุฌูุฏุฉ ูุจูู ูู
ุงู ุงู B ู
ุด ุฑุงุญ |
|
|
|
269 |
|
00:23:05,450 --> 00:23:09,350 |
|
ุชุดุชุบู. Congenital |
|
|
|
270 |
|
00:23:09,350 --> 00:23:13,890 |
|
Thymic Aplasia ุงููู ูู ุฏูุฌูุฑุฌ ุณูุฏุฑูู
. ูููุง ูุฐุง ูู |
|
|
|
271 |
|
00:23:13,890 --> 00:23:20,950 |
|
ู
ุฑุงุญู ู
ุจูุฑุฉ ุฌุฏุง ุจุตูุฑ ุฅุฐุง ูุงูุฑูู ูู ุฑูู
ุงุชููู ูู ุงูู |
|
|
|
272 |
|
00:23:20,950 --> 00:23:26,110 |
|
T cell hemopoietic maturation steps. ุงูู
ูู
ุฏู ุฌูุฑุฌ |
|
|
|
273 |
|
00:23:26,110 --> 00:23:31,070 |
|
ุณูุฏุฑูู
ุจูุนูู ุงูู ููู T cell deficiency ู in which |
|
|
|
274 |
|
00:23:31,070 --> 00:23:34,770 |
|
the cells must develop abnormally. ู
ุงููุด ุงูุด ู
ุงููุด |
|
|
|
275 |
|
00:23:34,770 --> 00:23:38,950 |
|
development. ูุจูู ู
ุงูู ุฅูุชุงุฌ ู T lymphocyte. no T |
|
|
|
276 |
|
00:23:38,950 --> 00:23:46,310 |
|
cell ู ูููู ุฅู ุงูุฎูู ูุงุชุฌ ุนู defective migration |
|
|
|
277 |
|
00:23:46,310 --> 00:23:51,420 |
|
of fetal neural crest cells. ุงูุซุงูุซุฉ ูุงูุชุงูุชุฉ |
|
|
|
278 |
|
00:23:51,420 --> 00:23:58,280 |
|
ู
ุตุทูุญุงุช ุงููุฑูุฌูุงู. ูุจุงูุชุงูู ุงูู
ุฑูุถ ุงููุงุฑุฏ ูุงูููุณ |
|
|
|
279 |
|
00:23:58,280 --> 00:24:05,480 |
|
ูุชุทูุฑ ุจุดูู ุทุจูุนู ูุจุฑุถู ุงูุซุงูู
ุณ ูุงูุจุฑุงุซูุฑููุฏ ูุง ูุชู
|
|
|
|
280 |
|
00:24:05,480 --> 00:24:08,820 |
|
ุชูููููุง. ูุฐุง ูุคุฏู ุฅูู ุซุงูู
ู ุฃุจููุฌูุง |
|
|
|
281 |
|
00:24:08,820 --> 00:24:14,640 |
|
ูhypoparathyroidism. ุซุงูู
ู |
|
|
|
282 |
|
00:24:14,640 --> 00:24:18,940 |
|
ุฃุจููุฌูุง ููุชูู ูู ู
ูุงุฌุฃุฉ ู
ุฏุฑุณุฉ ู
ุฏุฑุณุฉ ู
ุฏุฑุณุฉ ู
ุฏุฑุณุฉ |
|
|
|
283 |
|
00:24:19,890 --> 00:24:24,170 |
|
DiGeorge's syndrome ูู ู
ุด hereditary disease ูุงูู
ุง |
|
|
|
284 |
|
00:24:24,170 --> 00:24:31,990 |
|
ุจูุตูุฑ ููู Sporadic deficiency in chromosome 22q11 |
|
|
|
285 |
|
00:24:31,990 --> 00:24:36,990 |
|
or deletion. ุทุจุนุง ูุฏูู ุงูู
ุฑุถู ุจูุตูุฑ ูู ุนูุฏูู
|
|
|
|
286 |
|
00:24:36,990 --> 00:24:40,350 |
|
recurrent or chronic infection with viruses |
|
|
|
287 |
|
00:24:40,350 --> 00:24:47,810 |
|
ุจูุชูุฑูุง ููุฌุงู ุจุฑูุชูุฒูุง. ู ุงููุงุณ ูุฏูู ุนูุฏูู
ููุงุจ ูู |
|
|
|
288 |
|
00:24:47,810 --> 00:24:54,090 |
|
T cell.ุฃูุถูุง ูุดูุช ุชุฌุฑู ุนูู ุชุฌุงุฑุจ ุงูุงูุชุจุงู ูุฐู |
|
|
|
289 |
|
00:24:54,090 --> 00:24:56,730 |
|
ุงูุฃุดุฎุงุต ูุง ูุฌุจ ุฃู ูููููุง ู
ู
ูุฒูู ุจูุงุณุทุฉ ู
ูุงุฌูุฉ |
|
|
|
290 |
|
00:24:56,730 --> 00:24:58,610 |
|
ู
ูุงุฌูุฉ ู
ูุงุฌูุฉ ู
ูุงุฌูุฉ ู
ูุงุฌูุฉ ู
ูุงุฌูุฉ ู
ูุงุฌูุฉ ู
ูุงุฌูุฉ |
|
|
|
291 |
|
00:24:58,610 --> 00:25:02,910 |
|
ู
ูุงุฌูุฉ ู
ูุงุฌูุฉ ู
ูุงุฌูุฉ |
|
|
|
292 |
|
00:25:03,160 --> 00:25:06,740 |
|
with normal peripheral T cell number. ูุนูู ููู |
|
|
|
293 |
|
00:25:06,740 --> 00:25:12,140 |
|
normal T lymphocyte ููู ูู ููุณ ุงูููุช ูุดู ูุดู |
|
|
|
294 |
|
00:25:12,140 --> 00:25:17,960 |
|
function. ุงุฏู functional defect ูู T cell ุงูุถุง |
|
|
|
295 |
|
00:25:17,960 --> 00:25:22,260 |
|
opportunistic infection and high incidence of |
|
|
|
296 |
|
00:25:22,260 --> 00:25:27,140 |
|
autoimmune disease. ู
ูุงุญุธุงุช it's autosomal |
|
|
|
297 |
|
00:25:27,140 --> 00:25:32,200 |
|
recessive pattern. ูุทุจุนุง ูู ุนุจุงุฑุฉ ุนู heterogeneous |
|
|
|
298 |
|
00:25:32,200 --> 00:25:38,880 |
|
group.ุฃูุถุง ูุดู
ู ุบูุงุจ ูู ZAP-17 tyrosine kinase. CD3E |
|
|
|
299 |
|
00:25:38,880 --> 00:25:45,860 |
|
ูCD3G. ูู ูุฐู ุงูู
ููููููู ุงูู
ุชุนููุฉ ุจุงูุฅุดุนุงุฑ T-cell |
|
|
|
300 |
|
00:25:45,860 --> 00:25:55,840 |
|
ูุจุงูุชุงูู ู
ุงููุด ูุงููุดู. Autoimmune |
|
|
|
301 |
|
00:25:55,840 --> 00:26:01,920 |
|
lymphoproliferative disease. ุงูุฃูุถุงู ุฅููุง ุชุณู
ู ุจู |
|
|
|
302 |
|
00:26:01,920 --> 00:26:06,300 |
|
Inherited by Massive Proliferation of Lymphoid |
|
|
|
303 |
|
00:26:06,300 --> 00:26:08,980 |
|
Tissue. ูุจุฏุฃุช |
|
|
|
304 |
|
00:26:08,980 --> 00:26:27,160 |
|
ูุชุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุท |
|
|
|
305 |
|
00:26:32,150 --> 00:26:35,050 |
|
ุนุงู
ู ุงูู autoimmune lymphoproliferative ุงูุดุฎุตูุฉ ุฃู |
|
|
|
306 |
|
00:26:35,050 --> 00:26:43,170 |
|
ุงูุดุฎุตูุฉ ุงูุณููุงู
ูุฉ ูุฏููุง ู
ููุชูุดู ูู ุงูู FAS gene |
|
|
|
307 |
|
00:26:43,170 --> 00:26:51,870 |
|
ูุชุนุงู
ู ู
ุน ุงูู FAS protein CD95. ูุชุนุงู
ู ู
ุน ุงูู |
|
|
|
308 |
|
00:26:51,870 --> 00:27:00,350 |
|
Apoptosis signaling. ูุฏููู
ูุงุญุฏ ุทุจูุนู ููุงุญุฏ ู
ููุชูุช |
|
|
|
309 |
|
00:27:00,350 --> 00:27:07,140 |
|
FAS molecule. ูุฐุง ุจูุคุฏู or that mutated phase |
|
|
|
310 |
|
00:27:07,140 --> 00:27:11,140 |
|
molecule interferes with the function of normal |
|
|
|
311 |
|
00:27:11,140 --> 00:27:15,780 |
|
molecule. ุทุจุนุง ุงู mutated ูู ุงููู ุจูุชุฏุฎู ูู ุงู |
|
|
|
312 |
|
00:27:15,780 --> 00:27:20,420 |
|
function of normal molecule. These patients have |
|
|
|
313 |
|
00:27:20,420 --> 00:27:25,840 |
|
defect in other component of apoptosis pathway. ุฒู |
|
|
|
314 |
|
00:27:25,840 --> 00:27:29,120 |
|
ุงู Fas ligand or caspase 10 |
|
|
|
315 |
|
00:27:31,670 --> 00:27:37,270 |
|
Chronic Mucocutaneous Candidiasis. ุจูู ู
ู ุงูุงุณู
|
|
|
|
316 |
|
00:27:37,270 --> 00:27:42,250 |
|
Candidiasis ูุนูู ููู Candida infection of skin and |
|
|
|
317 |
|
00:27:42,250 --> 00:27:47,830 |
|
mucous membrane. ุบุงูุจุง ุงูู
ุฑุถู have normal T cell |
|
|
|
318 |
|
00:27:47,830 --> 00:27:52,070 |
|
mediated immunity to microorganism other than |
|
|
|
319 |
|
00:27:52,070 --> 00:27:56,810 |
|
Candida and normal B cell mediated immunity to all |
|
|
|
320 |
|
00:27:56,810 --> 00:28:04,190 |
|
microorganism ุจู
ุง ูููุง ุงู Candida. ูุนูู ุงูุฎูู ูู |
|
|
|
321 |
|
00:28:04,190 --> 00:28:09,210 |
|
ุงููุ ูู ุงู T-lymphocyte which can respond to all |
|
|
|
322 |
|
00:28:09,210 --> 00:28:12,930 |
|
the micro part ู
ุน ุงู Canada. ุจููู
ุง ุงู B-lymphocyte |
|
|
|
323 |
|
00:28:12,930 --> 00:28:17,350 |
|
is normal. They have selective defect in the |
|
|
|
324 |
|
00:28:17,350 --> 00:28:20,210 |
|
function of T cell. |
|
|
|
325 |
|
00:28:23,500 --> 00:28:28,520 |
|
ุงูุชุงูู ูู ุงู BCR immunoglobulin associated |
|
|
|
326 |
|
00:28:28,520 --> 00:28:33,400 |
|
immunodeficiency. ูุฃุดูุฑ |
|
|
|
327 |
|
00:28:33,400 --> 00:28:36,980 |
|
ู
ุซุงู ุนูู ุฐูู ุจุฑูุชูู ุงู ุฌุงู
ุง ุบููุจููุงููููุง. ููู ุนุจุงุฑุฉ |
|
|
|
328 |
|
00:28:36,980 --> 00:28:42,340 |
|
ุนู X-linked infantile ุงู ุฌุงู
ุง ุบููุจููุงููููุง. ุงูุฃุทูุงู |
|
|
|
329 |
|
00:28:42,340 --> 00:28:48,260 |
|
ู
ู Infanta ุงูุฃุทูุงู present with serious, repeated |
|
|
|
330 |
|
00:28:48,260 --> 00:28:52,390 |
|
infection. ูุณุจุจ ูู ุฐูู is severe depression or |
|
|
|
331 |
|
00:28:52,390 --> 00:28:56,710 |
|
virtual absence of all immunoglobulin. ูุญูุง ุจูุญูู |
|
|
|
332 |
|
00:28:56,710 --> 00:29:00,890 |
|
ุนูููุง ุจุฑูุชููุฒ. ูุนูู ู
ุงููุด ุจู ุณู ู
ุงููุด ุงูุด ุจู |
|
|
|
333 |
|
00:29:00,890 --> 00:29:06,650 |
|
lymphocyte. ู
ุนูุงุชู ู
ุงููุด antibody production. ุทุจุนุง |
|
|
|
334 |
|
00:29:06,650 --> 00:29:11,250 |
|
ุงู major defect ูุฌุฏูู ุงูู ูู ุนุฏู
ูุฏุฑุฉ ุงูุจูุช ุงููุง |
|
|
|
335 |
|
00:29:11,250 --> 00:29:19,290 |
|
ุชุชุทูุฑ to be mature as B cell. ุจุฑูุชูู ุฌูู |
|
|
|
336 |
|
00:29:20,990 --> 00:29:28,470 |
|
ุชู
ุชุบููุฑู ุจุทุฑููุฉ X ู
ุฑุชุจุทุฉ. ูุฐู |
|
|
|
337 |
|
00:29:28,470 --> 00:29:33,710 |
|
ุงูุฌููุงูุงุช ุชุฏุนู tyrosine kinase enzyme ู
ูุฌูุฏ ูู |
|
|
|
338 |
|
00:29:33,710 --> 00:29:39,150 |
|
ุงููCytosol. XLA |
|
|
|
339 |
|
00:29:39,150 --> 00:29:44,810 |
|
ุชู
ุชุญูุทู ูุนูู ุนููู ุงูู
ุชูุณุท ุงูู
ุชูุณุท |
|
|
|
340 |
|
00:29:44,810 --> 00:29:46,210 |
|
ุงูู
ูุฌูุฏ ูู ุงููCytoplasmic |
|
|
|
341 |
|
00:29:49,190 --> 00:29:53,930 |
|
Patients suffer repeated infection. Treatment ุทุจุนุง |
|
|
|
342 |
|
00:29:53,930 --> 00:29:57,490 |
|
Periodic injection of intravenous gamma globulin |
|
|
|
343 |
|
00:29:57,490 --> 00:30:04,670 |
|
ุจูุญุชูู ุนูู IgG. Transient |
|
|
|
344 |
|
00:30:04,670 --> 00:30:10,990 |
|
Hypo Gamma Globulinemia. ุงุณู
Transient ูู ุนู
ุฑ ุฎู
ุณุฉ |
|
|
|
345 |
|
00:30:10,990 --> 00:30:16,940 |
|
ูุณุช ุดููุฑ. ุจูุตูุฑ ููู Passively transferred from |
|
|
|
346 |
|
00:30:16,940 --> 00:30:26,980 |
|
maternal to fetus of IgG antibody. ูุทุจุนุง |
|
|
|
347 |
|
00:30:26,980 --> 00:30:36,140 |
|
ูู ูุฐู ุงูุญุงูุฉ ุจูุจุฏุฃ ุงู IGG ุจูุจุฏุฃ ูุธูุฑ |
|
|
|
348 |
|
00:30:36,140 --> 00:30:44,810 |
|
ุงููู ูู ุงู infant IgG. premature infant ู
ู
ูู ูุตูุฑ |
|
|
|
349 |
|
00:30:44,810 --> 00:30:49,570 |
|
ุนูุฏู Transient IgG Deficiency if they are not yet |
|
|
|
350 |
|
00:30:49,570 --> 00:30:55,050 |
|
able to synthesize immunoglobulin. Sometimes helper |
|
|
|
351 |
|
00:30:55,050 --> 00:30:59,630 |
|
T cells are deficient. ูุนูู ุจูุตูุฑ ููู ุบูุงุจ ูู ุงู T |
|
|
|
352 |
|
00:30:59,630 --> 00:31:04,030 |
|
lymphocyte help ูุจุงูุชุงูู ู
ุงููุด Antibody production |
|
|
|
353 |
|
00:31:04,030 --> 00:31:08,070 |
|
ุฃู B cell functioning. ูุนูู ู
ุงููุด ุดูุก. This disease |
|
|
|
354 |
|
00:31:08,070 --> 00:31:10,310 |
|
may persist for a few months. ู |
|
|
|
355 |
|
00:31:12,600 --> 00:31:17,900 |
|
ุจุงููุชูุฑ ูุบุงูุฉ ุณูุชูู. It's not X-linked and should |
|
|
|
356 |
|
00:31:17,900 --> 00:31:24,240 |
|
be distinguished from X-linked disease. ุฎูุงู ูุฌูุฏ |
|
|
|
357 |
|
00:31:24,240 --> 00:31:29,460 |
|
ุงู normal number of B cells. Immunization should |
|
|
|
358 |
|
00:31:29,460 --> 00:31:33,800 |
|
not be given during this period. Common variable |
|
|
|
359 |
|
00:31:33,800 --> 00:31:38,120 |
|
immunodeficiency. ู
ู ุงูุฅุณู
it's characterized by |
|
|
|
360 |
|
00:31:38,120 --> 00:31:39,280 |
|
ุบูุงุจ |
|
|
|
361 |
|
00:31:43,570 --> 00:31:51,510 |
|
ู
ุงุดู or reduction in the serum IgG ู IgA ู ุจูููู ูู |
|
|
|
362 |
|
00:31:51,510 --> 00:31:57,890 |
|
ุนูุฏู IgM normal or low ู ุทุจุนุง ูู normal or low |
|
|
|
363 |
|
00:31:57,890 --> 00:32:03,950 |
|
number of B cell. ุงู B cell fails to mature |
|
|
|
364 |
|
00:32:03,950 --> 00:32:09,650 |
|
into plasma cell.ูุงูู
ุฑุถู have recurrent respiratory |
|
|
|
365 |
|
00:32:09,650 --> 00:32:13,550 |
|
and gastrointestinal infection. Treatment by |
|
|
|
366 |
|
00:32:13,550 --> 00:32:22,850 |
|
intravenous immunoglobulin. Selective |
|
|
|
367 |
|
00:32:22,850 --> 00:32:29,160 |
|
immunoglobulin deficiency. ุงูู IgA-Deficiency ุบุงูุจุง |
|
|
|
368 |
|
00:32:29,160 --> 00:32:31,860 |
|
ู
ุฑุถู ุจุณ ูููู ุนูุฏูู
recurrent viral or bacterial |
|
|
|
369 |
|
00:32:31,860 --> 00:32:35,300 |
|
infection, celiac disease, defective absorption |
|
|
|
370 |
|
00:32:35,300 --> 00:32:39,060 |
|
and repeal ุงููู ูู ุนุจุงุฑุฉ ุนู ุงูู celiac or maybe |
|
|
|
371 |
|
00:32:39,060 --> 00:32:43,720 |
|
entirely asymptomatic. Treatment ุจุฏู pro-the |
|
|
|
372 |
|
00:32:43,720 --> 00:32:47,360 |
|
spectrum antibiotic. IgM-Deficiency, rare |
|
|
|
373 |
|
00:32:47,360 --> 00:32:52,300 |
|
disorder. ูุทุจุนุง ุงูู
ุฑุถู ุจูุนุงููุง ู
ู recurrent and |
|
|
|
374 |
|
00:32:52,300 --> 00:32:54,740 |
|
severe infection with polysaccharide antigen |
|
|
|
375 |
|
00:32:54,740 --> 00:32:59,840 |
|
-encapsulated organism. ุฒู pneumonia ุฃู pneumococci |
|
|
|
376 |
|
00:32:59,840 --> 00:33:05,040 |
|
and hemophilus inflammation ุงู disorders of T and |
|
|
|
377 |
|
00:33:05,040 --> 00:33:11,780 |
|
B interaction ุฒู ุงู-hyper IgM syndrome ููู ุนุจุงุฑุฉ ุนู |
|
|
|
378 |
|
00:33:11,780 --> 00:33:18,150 |
|
X-linked hyper IgM syndrome Present with |
|
|
|
379 |
|
00:33:18,150 --> 00:33:22,530 |
|
recurrent respiratory infection ู
ู ุฃูู ุณูุฉ ุฅูู |
|
|
|
380 |
|
00:33:22,530 --> 00:33:27,670 |
|
ุณูุชูู ู
ู ุงูุนู
ุฑ ู
ูุชูุดู ู
ูุฌูุฏุฉ ูู CD40-ligand gene |
|
|
|
381 |
|
00:33:27,670 --> 00:33:32,010 |
|
ุงูู
ูุฌูุฏ ุนูู ุงูู X chromosome ุงููู ูุจูู ุจูุคุฏู ุฅูู |
|
|
|
382 |
|
00:33:32,010 --> 00:33:37,890 |
|
CD40-ligand ูุจุงูุชุงูู ูู ุงูุดูุก |
|
|
|
383 |
|
00:33:40,910 --> 00:33:45,050 |
|
ุณูุฌูุงู ุชุฑุงูุฒุฏูุดู ูุนูู ู
ุงููุด ูุงููุดู ููู CD40 ููุฌุงูุฏ |
|
|
|
384 |
|
00:33:45,050 --> 00:33:50,390 |
|
ุจุฑุช ู
ุน CD40 ู
ูุฌูุฏ ุนูู ุณุทุญ ุงูู B lymphocytes ูุทุจุนุง this |
|
|
|
385 |
|
00:33:50,390 --> 00:33:57,810 |
|
interaction rescues the B cell from apoptosis X |
|
|
|
386 |
|
00:33:57,810 --> 00:34:00,990 |
|
-linked lymphoproliferative disease Duncan |
|
|
|
387 |
|
00:34:00,990 --> 00:34:08,070 |
|
syndrome ููุฐู ุจูุตูุฑ ูููุง ุนุฏู
ูุฏุฑุฉ ุนูุฏ ุงูู T cell to |
|
|
|
388 |
|
00:34:08,070 --> 00:34:13,700 |
|
regulate B cell growth ููู ุจูุนุชุจุฑ major part of the |
|
|
|
389 |
|
00:34:13,700 --> 00:34:19,820 |
|
underlying disease |
|
|
|
390 |
|
00:34:19,820 --> 00:34:24,220 |
|
ูุนูู this mechanism deficiency ูู ุงูุฃุณุงุณ ูู |
|
|
|
391 |
|
00:34:24,220 --> 00:34:29,730 |
|
ุงูู
ูุถูุน lymphoma incidence is high ูุงูุชูู ููู |
|
|
|
392 |
|
00:34:29,730 --> 00:34:35,090 |
|
phagocytic function ููุท |
|
|
|
393 |
|
00:34:35,090 --> 00:34:40,930 |
|
ููุชุฐููุฑ ุงูู phagocytic function ูุนูู ุฅุฐุง ูุงู ููู ุฎูู ูู |
|
|
|
394 |
|
00:34:40,930 --> 00:34:48,910 |
|
ุฎุทูุงุช ุงูู phagocytosis ููุท ููุชุฐููุฑ phagocytosis ุฎุทูุงุช |
|
|
|
395 |
|
00:34:48,910 --> 00:34:54,620 |
|
ุงูู phagocytosis ูู ุงูู Adhesion ุซู
ุงูู Diapedesis ุซู
ุงูู |
|
|
|
396 |
|
00:34:54,620 --> 00:35:00,340 |
|
chemotaxis ุซู
ุงูู Phagocytosis ุซู
ุงูู Killing ู |
|
|
|
397 |
|
00:35:00,340 --> 00:35:07,080 |
|
ุงูุชุงูู ูู ุบูุงุจ ูู ูู ู
ุฑุญูุฉ ู
ู ุงูู
ุฑุงุญู ูุฐู ูุคุฏู ููุง |
|
|
|
398 |
|
00:35:07,080 --> 00:35:11,280 |
|
ูู ู
ุฑุญูุฉ is combined or is associated with certain |
|
|
|
399 |
|
00:35:11,280 --> 00:35:18,460 |
|
disease ู
ุงุดู ุฅุฐุง ุตุงุฑ ููู ุจุฑุถู ุฎูู ู
ุถุฑู ู
ุนูุงุชู ูู |
|
|
|
400 |
|
00:35:18,460 --> 00:35:22,550 |
|
ุงูู
ุฑุงุญู ุงููู ูุฏ ุชูููุง ูุงููุฉ ูุฅุฐุง ูุงู ุงูุฎูู ุญุฏุซ |
|
|
|
401 |
|
00:35:22,550 --> 00:35:27,990 |
|
ู
ุซููุง ู
ุซููุง ูู ุงูู LAD ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง |
|
|
|
402 |
|
00:35:27,990 --> 00:35:29,070 |
|
ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง |
|
|
|
403 |
|
00:35:29,070 --> 00:35:32,470 |
|
ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง |
|
|
|
404 |
|
00:35:32,470 --> 00:35:33,030 |
|
ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง |
|
|
|
405 |
|
00:35:33,030 --> 00:35:37,450 |
|
ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง |
|
|
|
406 |
|
00:35:37,450 --> 00:35:43,450 |
|
ู
ุซููุง ู
ุซููุง ู
ุซููุง ู
ุซููุง |
|
|
|
407 |
|
00:35:44,920 --> 00:35:49,480 |
|
LAD ูู ุจุฑูุงู
ุฌ group of disorders ุจูุชู
ูุฒ ุจุฃูู ุจูุตูุฑ |
|
|
|
408 |
|
00:35:49,480 --> 00:35:52,560 |
|
ููู ุฎูู ูู ุงูู interaction ู
ุง ุจูู ุงูู leukocyte ู
ุน |
|
|
|
409 |
|
00:35:52,560 --> 00:36:00,660 |
|
ุงูู vascular endothelial cells ูุทุจุนุง ูุงู ุงูู
ุฑุงุญู |
|
|
|
410 |
|
00:36:00,660 --> 00:36:04,700 |
|
ุทุจุนุง ุฌุงููุง ููู ุฃูุซุฑ ู
ู ู
ุฑุญูุฉ ููู LAD disease ู |
|
|
|
411 |
|
00:36:04,700 --> 00:36:09,240 |
|
ูุณู
ููุง ูุซูุงุซ ู
ุฑุงุญู LAD 1, LAD 2, LAD 3 ูุฒู ู
ุง |
|
|
|
412 |
|
00:36:09,240 --> 00:36:13,400 |
|
ุงูุชูุง ุดุงูููู ูู LAD 1 ุจูุตูุฑ ููู ุฎูู ูู ุงูู diapedesis |
|
|
|
413 |
|
00:36:15,830 --> 00:36:20,730 |
|
ูู ุงูู LAD 2 ุจูุตูุฑ ููู ุฎูู ูู ุงูู adhesion ูู ุงูู LAD |
|
|
|
414 |
|
00:36:20,730 --> 00:36:23,330 |
|
3 ุจูุตูุฑ ููู ุฎูู ูู ุงูู activation ุงููู ูู |
|
|
|
415 |
|
00:36:23,330 --> 00:36:27,450 |
|
ุงูู Phagocytosis ุจูุตูุฑ ูููุง ุฎูู ู
ุงุดู ุงูููู
ุจูุตูุฑ ููู |
|
|
|
416 |
|
00:36:27,450 --> 00:36:33,290 |
|
ุฎูู ูู ูุงุญุฏ ุงููู ูู ุงูู adhesion ุฃูู ูุงุญุฏุฉ ุจูุตูุฑ |
|
|
|
417 |
|
00:36:33,290 --> 00:36:38,130 |
|
ููู ุฎูู ูู ูู ูุฐู ุงูู
ุฑุงุญู ู
ุงุดู ูุงูููู
ุจูุตูุฑ ููู |
|
|
|
418 |
|
00:36:38,130 --> 00:36:41,270 |
|
ุฎูู ูู ุฃุฎุฑ ูุงุญุฏุฉ ุงููู ูู ุงูู activation ุทุจุนุง ุจูุญุตู |
|
|
|
419 |
|
00:36:41,270 --> 00:36:51,110 |
|
ููู ุฃู
ุฑุงุถ ุฒู ุงูู Chediak Higashi Syndrome ู ุงูู CDD ูุงู |
|
|
|
420 |
|
00:36:51,110 --> 00:36:53,510 |
|
ุงููู ูุงุฏ ูุงุญุฏ ุญุถุฑ ุนู ุงูู autosomal recessive |
|
|
|
421 |
|
00:36:53,510 --> 00:36:58,870 |
|
disease ู
ุฑุชุจุทุฉ ุจุงููุฑูู
ูุฒูู
ุฑูู
22 ุงูู
ุฑุถู ุนูุฏูู
ุงูู |
|
|
|
422 |
|
00:36:58,870 --> 00:37:03,690 |
|
effect ุฅู ูุชููู subunits of integrin molecule ููุฐุง |
|
|
|
423 |
|
00:37:03,690 --> 00:37:09,210 |
|
ุจูุคุฏู ุฅูู ุงููู ูู ุฅูู adhesion to feel adhesion |
|
|
|
424 |
|
00:37:09,210 --> 00:37:12,740 |
|
and migration of all white blood cells in the body |
|
|
|
425 |
|
00:37:14,860 --> 00:37:18,980 |
|
ูู ุงูุฃุฏููุฉ ุงูู
ุฑุถู ุจูุญุตู ุนูุฏูู
recurrent soft tissue |
|
|
|
426 |
|
00:37:18,980 --> 00:37:22,760 |
|
bacterial infection ููุฒูุฏ ุงูููุช blood cell count |
|
|
|
427 |
|
00:37:22,760 --> 00:37:27,540 |
|
ููู ุจุฏูู pus formation ูุนูู ู
ุงููุด activity ูู
ุงููุด |
|
|
|
428 |
|
00:37:27,540 --> 00:37:31,060 |
|
ูู ุงูุฃุฎู
ุงุช ุงููู ูุฑุง ุงูู adhesion ุฃู ุงูู effecting |
|
|
|
429 |
|
00:37:31,060 --> 00:37:35,140 |
|
wound healing lymphocyte function is also affected |
|
|
|
430 |
|
00:37:35,140 --> 00:37:39,500 |
|
due to the lack of lymphocyte functioning antigen |
|
|
|
431 |
|
00:37:39,500 --> 00:37:44,860 |
|
presentation ุงูู LAD 2 ูููุง ุจูุตูุฑ ููู defect in |
|
|
|
432 |
|
00:37:44,860 --> 00:37:50,180 |
|
selecting ุงูู ligand ูุงูู underlying defect ุงููู |
|
|
|
433 |
|
00:37:50,180 --> 00:37:54,400 |
|
ูู LAD 2 ุจูุตูุฑ |
|
|
|
434 |
|
00:37:54,400 --> 00:37:58,700 |
|
ููู ุฃูุถูุง ุฎูู ูู ุงูู leukocyte function ู ุฏู ุจูุคุฏู |
|
|
|
435 |
|
00:37:58,700 --> 00:38:03,140 |
|
ุฅูู ุบูุงุจ ุงูู leukocyte ligand for selecting to be |
|
|
|
436 |
|
00:38:03,140 --> 00:38:08,560 |
|
bind ูุฏู ู
ุซู ุฃู ุตูุฑุฉ ุญููุฉ ููุฐุง ุงูู
ูุถูุน ุงูู LAD ูุงุญุฏ |
|
|
|
437 |
|
00:38:08,560 --> 00:38:18,290 |
|
ูู ุงูุดูุก ูู ุนุจุงุฑุฉ ุนู antigen ู
ุงุดู LAD ุงุชููู ุนุจุงุฑุฉ ุนู |
|
|
|
438 |
|
00:38:18,290 --> 00:38:24,270 |
|
rolling Selected ุชููู ุบูุฑ ุฑูู
ุชูุงุชุฉ ุงููู ูู ุงูู |
|
|
|
439 |
|
00:38:24,270 --> 00:38:31,110 |
|
activation is defected ุทุจุนุง ูุฐุง ููู ูู LAD ูุงุญุฏ ุจุณ |
|
|
|
440 |
|
00:38:31,110 --> 00:38:36,070 |
|
ููู ุฎูู ูู ุงูุงุฑุชุจุงุท ูุงูู transmigration ุงููู ูู |
|
|
|
441 |
|
00:38:45,690 --> 00:38:52,590 |
|
ุงูู integrins ุงู ุงูู organelles ุจูุตูุฑ |
|
|
|
442 |
|
00:38:52,590 --> 00:38:57,750 |
|
ูู ุนูุฏูุง ููุฉ ูู ุงูู interest of the organism ู this |
|
|
|
443 |
|
00:38:57,750 --> 00:39:00,470 |
|
results in |
|
|
|
444 |
|
00:39:02,700 --> 00:39:11,060 |
|
phagosome formation |
|
|
|
445 |
|
00:39:11,060 --> 00:39:11,740 |
|
phagosome formation |
|
|
|
446 |
|
00:39:11,740 --> 00:39:17,280 |
|
phagosome formation |
|
|
|
447 |
|
00:39:17,280 --> 00:39:22,200 |
|
phagosome formation |
|
|
|
448 |
|
00:39:23,380 --> 00:39:26,020 |
|
ู
ุฎููู ูุจูุฑ ู
ู ุงูู
ุฎููู |
|
|
|
449 |
|
00:39:26,020 --> 00:39:27,180 |
|
ุงูู
ุฎููู |
|
|
|
450 |
|
00:39:27,180 --> 00:39:30,020 |
|
ุงูู
ุฎููู |
|
|
|
451 |
|
00:39:30,020 --> 00:39:31,620 |
|
ุงูู
ุฎููู |
|
|
|
452 |
|
00:39:31,620 --> 00:39:33,240 |
|
ุงูู
ุฎููู |
|
|
|
453 |
|
00:39:33,240 --> 00:39:38,680 |
|
ุงูู
ุฎููู |
|
|
|
454 |
|
00:39:38,680 --> 00:39:40,940 |
|
ุงูู
ุฎููู |
|
|
|
455 |
|
00:39:40,940 --> 00:39:46,160 |
|
ุงูู
ุฎููู |
|
|
|
456 |
|
00:39:48,980 --> 00:39:53,040 |
|
ูุจุงูุชุงูู ุจูุญุตู ููู ุนู
ููุฉ Phagocytosis ููู ู
ุงููู |
|
|
|
457 |
|
00:39:53,040 --> 00:39:57,600 |
|
killing ูุจูุญุตู ููู intracellular survival |
|
|
|
458 |
|
00:39:57,600 --> 00:40:03,060 |
|
ูุงูorganism ุจูุคุฏู ุฅูู granuloma formation Mutation |
|
|
|
459 |
|
00:40:03,060 --> 00:40:06,380 |
|
ูุฌุฏููุง ูู ุงูู enzymes which catalyzes the |
|
|
|
460 |
|
00:40:06,380 --> 00:40:10,800 |
|
respiratory burst ูุจูุญุตู |
|
|
|
461 |
|
00:40:10,800 --> 00:40:17,120 |
|
ููู ููุฉ ูู ุงูู intracellular killing ู
ุญุตูุฉ ุฃู ุบูุงุจ |
|
|
|
462 |
|
00:40:19,320 --> 00:40:22,700 |
|
ูุจููุงุญุธ ูุฐู ุงูุญุงูุงุช ูู ุฃูู ุดูุฑ ุฃู ุฃูู ุณูุชูู ู
ู |
|
|
|
463 |
|
00:40:22,700 --> 00:40:31,400 |
|
ุงูุนู
ุฑ ุจูุตูุฑ ุนูุฏู recurrent infection ุญุชู ุฃุถุนู ุงูู |
|
|
|
464 |
|
00:40:31,400 --> 00:40:35,660 |
|
microbes ู
ุฑุฉ |
|
|
|
465 |
|
00:40:35,660 --> 00:40:40,720 |
|
ุขุฎุฑ interferon gamma receptor deficiency ุจูุตูุฑ ููู |
|
|
|
466 |
|
00:40:40,720 --> 00:40:43,900 |
|
mutation ูู ุงูู interferon ุนุงุฆูุฉ ุฃุฎุฑู ู
ู ุนุงุฆูุงุช ุงูู |
|
|
|
467 |
|
00:40:43,900 --> 00:40:48,030 |
|
receptor ุจูุคุฏู ุฅูู inability of a monocyte to |
|
|
|
468 |
|
00:40:48,030 --> 00:40:53,450 |
|
respond to Gamma Interferon ูุจุงูุชุงูู |
|
|
|
469 |
|
00:40:53,450 --> 00:40:56,430 |
|
ูู ุงูู secretion of the tumor necrosis factor Alpha |
|
|
|
470 |
|
00:40:56,430 --> 00:41:01,850 |
|
ุงูู patients are susceptible to weakly pathogenic |
|
|
|
471 |
|
00:41:01,850 --> 00:41:03,290 |
|
mycobacteria |
|
|
|
472 |
|
00:41:06,330 --> 00:41:10,090 |
|
ูู ุงูู Natural Killer Cell Deficiency ุงููู ูุนุฑูู |
|
|
|
473 |
|
00:41:10,090 --> 00:41:15,130 |
|
ุจูุฃุซุฑ ุนูู ุงูู NK cell ุจูุคุฏู ุฅูู ุงูู Impaired |
|
|
|
474 |
|
00:41:15,130 --> 00:41:19,090 |
|
Allograft Rejection ู
ุงููุด ุดูุก ุงูู Impairment |
|
|
|
475 |
|
00:41:19,090 --> 00:41:24,930 |
|
Rejection And is linked to higher susceptibility |
|
|
|
476 |
|
00:41:24,930 --> 00:41:29,170 |
|
to viral disease ูุจูุตูุฑ ููู metastasis from tumor |
|
|
|
477 |
|
00:41:31,140 --> 00:41:36,500 |
|
ุงูู NK cells seen in Skid some T and phagocytic |
|
|
|
478 |
|
00:41:36,500 --> 00:41:40,540 |
|
cell disorder and in X-linked lymphoproliferative |
|
|
|
479 |
|
00:41:40,540 --> 00:41:47,360 |
|
syndrome ุงูุงูุฑุงู |
|
|
|
480 |
|
00:41:47,360 --> 00:41:56,880 |
|
ุงููู ุจุชุชุนูู ุจุงูู complement ูุนูู ุงูู ..ุงูู |
|
|
|
481 |
|
00:41:56,880 --> 00:42:00,180 |
|
complement component ุงูุงููุงููุฉ ู
ูู
ุฉ ุฌุฏุง for |
|
|
|
482 |
|
00:42:00,180 --> 00:42:07,300 |
|
opsonization ุฒู C3P ุบุงูุจุง deficiency of complement is |
|
|
|
483 |
|
00:42:07,300 --> 00:42:14,700 |
|
associated with SLE disease ููู ุงูู complement |
|
|
|
484 |
|
00:42:14,700 --> 00:42:22,740 |
|
ุจุชุดุชุบู ุจู
ููุงูุฒู
classical ู alternative ุทุจุนุง |
|
|
|
485 |
|
00:42:22,740 --> 00:42:32,270 |
|
ุฒู ู
ุง ุงูุชูุง ุดุงูููู ุงููู ูู ุณูุงุก ูุงู alternative ุงู |
|
|
|
486 |
|
00:42:32,270 --> 00:42:38,110 |
|
lectin pathway ุงู even classical ุบูุงุจูุง ุจูุฏู ูู diseases |
|
|
|
487 |
|
00:42:38,110 --> 00:42:42,330 |
|
ู
ุฎุชููุฉ ููู ุงูุจุฏุงูุฉ infections with |
|
|
|
488 |
|
00:42:42,330 --> 00:42:46,630 |
|
encapsulated microorganism ุจูุฏู
ุดููุฉ rheumatoid |
|
|
|
489 |
|
00:42:46,630 --> 00:42:51,190 |
|
disease ูุงุณุฆูุฉ ุงูู ุชุญุช ุงุฐุง ูุงู ูู ุงูู
ุงู ุงู ุงูู |
|
|
|
490 |
|
00:42:51,190 --> 00:42:56,830 |
|
membrane attack complex ุจูุตูุฑ ููู Neisseria gonorrhoeae ุงู |
|
|
|
491 |
|
00:42:56,830 --> 00:43:03,260 |
|
Neisseria meningitidis ุฃู ู
ุฑูุถ ุจู Deficiency of C1,4,2 ุงููู |
|
|
|
492 |
|
00:43:03,260 --> 00:43:07,160 |
|
ูู ุงูุจุฏุงูุงุช ู
ู ุงูู Classical Pathway ุงู C3 |
|
|
|
493 |
|
00:43:07,160 --> 00:43:11,100 |
|
Deficiency ููุณูุง ุจูุตูุฑ ููู ุฒูุงุฏุฉ ูู ุงูู Infection |
|
|
|
494 |
|
00:43:11,100 --> 00:43:14,180 |
|
ุฃู ุงูู Encapsulated Microorganism ุญุณุจ ุงูุฌุฏูู ุงููู |
|
|
|
495 |
|
00:43:14,180 --> 00:43:18,080 |
|
ุดููุงู ุทูู ุฒู Streptococcus pneumoniae ู ุงูู Haemophilus |
|
|
|
496 |
|
00:43:18,080 --> 00:43:24,720 |
|
ู ุงูุงูููููุฒุง ู ุฃุฒู
ุฉ ุฑูู
ุงุชูุฒู
ูุฉ ุจุณุจุจ ุชูุธูู ุบูุฑ ุตุญูุญ |
|
|
|
497 |
|
00:43:24,720 --> 00:43:25,480 |
|
ููู
ุนุงู
ูุงุช ุงูู
ูุงุนูุฉ |
|
|
|
498 |
|
00:43:29,040 --> 00:43:33,640 |
|
ุงูู Deficiency of the mannose binding lectin |
|
|
|
499 |
|
00:43:33,640 --> 00:43:38,100 |
|
ุจูุคุฏู ุงูู ุทุจุนุง ุงูู
ูุฌูุฏ ุนูู ุงูู surface of microbe |
|
|
|
500 |
|
00:43:38,100 --> 00:43:45,040 |
|
with or without antibody and activate the |
|
|
|
501 |
|
00:43:45,040 --> 00:43:50,240 |
|
classical pathwayุฃูุถูุง ุจูุคุฏู ุบูุงุจู ุฅูู risk of |
|
|
|
502 |
|
00:43:50,240 --> 00:43:56,380 |
|
infection and SLE-like symptoms. ุบูุงุจ C3 associated |
|
|
|
503 |
|
00:43:56,380 --> 00:44:04,700 |
|
with symptoms ุฎุตูุตูุง ุงูู complications ุชุจุนุชูุง ุบูุงุจ |
|
|
|
504 |
|
00:44:04,700 --> 00:44:08,480 |
|
ุงูู lead complement component ูู ุงูุขุฎุฑ ูุนูู ุงูู MAC |
|
|
|
505 |
|
00:44:08,480 --> 00:44:14,160 |
|
ุฒู C56789 ุงููู ุจูููููุง ุงูู MAC ุงููู ูู membrane |
|
|
|
506 |
|
00:44:14,160 --> 00:44:21,270 |
|
attack complex. It's directly related to the primary |
|
|
|
507 |
|
00:44:21,270 --> 00:44:27,010 |
|
defect against gram-negative bacteria ุฎุตูุตูุง |
|
|
|
508 |
|
00:44:27,010 --> 00:44:30,450 |
|
ููุณูุฑูุง. Defective |
|
|
|
509 |
|
00:44:30,450 --> 00:44:34,010 |
|
control of the complement component. ูุนูู ุญุชู ุงูู |
|
|
|
510 |
|
00:44:34,010 --> 00:44:37,930 |
|
control ุฅุฐุง ุตุงุฑ ููู deficiency ุฒู ุงูู hereditary |
|
|
|
511 |
|
00:44:37,930 --> 00:44:43,850 |
|
angioedema. ู
ุดููุฑุฉ ูุชูุฑ ุบูุงุจ C1 esterase inhibitor |
|
|
|
512 |
|
00:44:45,150 --> 00:44:51,370 |
|
ุจูุฏู ุงูู ุงููู ูู ุงูู hereditary angioedema ุทุจุนุง |
|
|
|
513 |
|
00:44:51,370 --> 00:44:54,590 |
|
ูู
ูุฉ ูุจูุฑุฉ ู
ู ุงูู vasoactive peptide. patient |
|
|
|
514 |
|
00:44:54,590 --> 00:44:59,370 |
|
suffering from localized edema. ู it's life |
|
|
|
515 |
|
00:44:59,370 --> 00:45:03,850 |
|
threatening when it occurs in the larynx. ุงู ุทุจุนุง |
|
|
|
516 |
|
00:45:03,850 --> 00:45:07,230 |
|
ุจูุตูุฑ ููู ุงุด edema ูู ุงูู larynx ู ุงูุชุงูู ุจูุตูุฑ ููู |
|
|
|
517 |
|
00:45:07,230 --> 00:45:12,730 |
|
obstruction ููู airway pathway. treatment |
|
|
|
518 |
|
00:45:12,730 --> 00:45:19,410 |
|
ุบุงูุจุง avoid trauma and infusion of C1 esterase |
|
|
|
519 |
|
00:45:19,410 --> 00:45:25,350 |
|
inhibitor. ุงูุฌููููุฒูู ุงููุณูุฉ ุฏู ุงูู enacetol protein |
|
|
|
520 |
|
00:45:25,350 --> 00:45:33,270 |
|
deficiency. ูุนุฑู ุงู ูุฐุง ุจูุนุจ ุฏูุฑ ูุจูุฑ ูู ุงูู as |
|
|
|
521 |
|
00:45:33,270 --> 00:45:35,670 |
|
anchored protein. |
|
|
|
522 |
|
00:45:37,690 --> 00:45:44,190 |
|
ูุฐุง ุนุจุงุฑุฉ ุนู ุนุงุฆูุฉ ู
ู ุงูุจุฑูุชููุงุช ูุงูุฌููููุฒูู |
|
|
|
523 |
|
00:45:44,190 --> 00:45:48,530 |
|
ุงูููุณูุงุช ุฏูุงู ุงููุงุณูุชูู ุงูุงููููุงุช is expressed ุนูู |
|
|
|
524 |
|
00:45:48,530 --> 00:45:51,110 |
|
ุงูู membrane of RBCs, lymphocyte, granulocyte |
|
|
|
525 |
|
00:45:51,110 --> 00:45:54,590 |
|
endothelial cell and epithelial cell. ู
ุนุธู
ุงูุฎูุงูุง |
|
|
|
526 |
|
00:45:55,790 --> 00:45:58,450 |
|
ุทุจุนุง DC protein ูู
ุนุจุงุฑุฉ ุนู ุงูุจุฑูุชููุงุช ุญู
ุงูุฉ |
|
|
|
527 |
|
00:45:58,450 --> 00:46:02,930 |
|
ููุฎูุงูุง ู
ู ุงูู complement activity ูุจุงูุชุงูู ุบูุงุจูู
|
|
|
|
528 |
|
00:46:02,930 --> 00:46:12,770 |
|
ูุคุฏู ุฅูู ุบูุงุจ ุงูู destruction of cell. ุทุจุนุง |
|
|
|
529 |
|
00:46:12,770 --> 00:46:20,730 |
|
ูู ุงูุฎูุงูุง ุชุชุฃุซุฑ ูู ูุฐุง ุงูู
ูุถูุน ูุจุงูุชุงูู the ุฃูุถุง |
|
|
|
530 |
|
00:46:22,580 --> 00:46:26,300 |
|
ุจูุตูุฑ ููู hemolysis for all these cells. ุทุจุนุง ุฃุดูุฑ |
|
|
|
531 |
|
00:46:26,300 --> 00:46:29,800 |
|
ูุฐู ููุบุงูุฉ ุงููู ูู ุงูู PNH. ูู ุงูู PNH ุทุจุนุง ุงูู |
|
|
|
532 |
|
00:46:29,800 --> 00:46:33,760 |
|
patient ุจูุตูุฑ ููู ุบูุงุจ ููู enzyme required for |
|
|
|
533 |
|
00:46:33,760 --> 00:46:39,840 |
|
production of GBI ุงููู ูู ูุจุงูุชุงูู ู
ุงููุด GBI ุนููู
|
|
|
|
534 |
|
00:46:39,840 --> 00:46:43,680 |
|
ุงูู protein ูุจุงูุชุงูู ู
ุงููุด ุจุฑูุชููุงุช ุญู
ุงูุฉ ุนุดุงู ููู |
|
|
|
535 |
|
00:46:43,680 --> 00:46:50,200 |
|
ุจุฒูุฏ ุงูู susceptibility to hemolysis ูู ุงูู Chronic |
|
|
|
536 |
|
00:46:50,200 --> 00:46:53,580 |
|
course of P.N.H. Intravascular Hemolysis or CARE |
|
|
|
537 |
|
00:46:53,580 --> 00:46:59,060 |
|
ุทุจุนุง ูู ุงููุฏูู ููุฐุง ุจููุฏู ุงูู ุงููู ููุง activation |
|
|
|
538 |
|
00:46:59,060 --> 00:47:03,700 |
|
of complement. ูุนูู ูู degeneration ููุชุดู ุฃู damage |
|
|
|
539 |
|
00:47:03,700 --> 00:47:08,740 |
|
ููุชุดู ููุชููู |
|
|
|
540 |
|
00:47:08,740 --> 00:47:12,520 |
|
ููุง ููุณุชูู
ู |
|
|
|
541 |
|
00:47:12,520 --> 00:47:14,220 |
|
ูู ู
ุฑุญูุฉ ูุงุฏู
ุฉ ุงู ุดุงุก ุงููู |
|
|